Fig. 4From: MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancerThe influence of LINC01296/ miR-29c-3p axis on the invasion and migration of OC cells. We treated the SKOV3 and OVCAR3 cells with miR-29c-3p inhibitor, si-LINC01296, or miR-29c-3p inhibitor plus si-LINC01296. Transwell assay (a-d) was carried out to test the invasion and migration of OC cells in different conditions. **P < 0.01 vs. control group, ##P < 0.01 vs. miR-29c-3p inhibitor groupBack to article page